Biogen Inc (NASDAQ:BIIB)

321.17
Delayed Data
As of Feb 21
 -13.99 / -4.17%
Today’s Change
249.17
Today|||52-Week Range
388.67
+6.73%
Year-to-Date

Today’s Trading

Previous close335.16
Today’s open329.97
Day’s range320.39 - 331.49
Volume1,441,537
Average volume (3 months)1,360,976
Market cap$65.4B
Data as of 4:00pm ET, 02/21/2019

Growth & Valuation

Earnings growth (last year)+3.38%
Earnings growth (this year)+9.77%
Earnings growth (next 5 years)+7.70%
Revenue growth (last year)+9.67%
P/E ratio14.9
Price/Sales5.13
Price/Book5.03

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc-5.36-1.77%
GILDGilead Sciences-1.43-2.13%
TLRYTilray Inc-1.90-2.34%
NBIXNeurocrine Bioscienc...-2.05-2.58%
Data as of 4:15pm ET, 02/21/2019

Financials

Next reporting dateApril 23, 2019
EPS forecast (this quarter)$6.92
Annual revenue (last year)$12.1B
Annual profit (last year)$4.4B
Net profit margin36.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Jeffrey D. Capello
Corporate headquarters
Cambridge, Massachusetts

Forecasts